Cargando…
The use of 5-aminosalicylates in Crohn’s disease: a retrospective study using the UK Clinical Practice Research Datalink
BACKGROUND: There are few recent studies on the use of 5-aminosalicylates (5-ASA) as therapy for Crohn’s disease (CD) in routine clinical practice. The aim of this database investigation was to provide real-world evidence on 5-ASA use in CD. METHODS: Patients with CD, aged ≥18 years when first presc...
Autores principales: | Hart, Ailsa, Ng, Siew C., Watkins, John, Paridaens, Kristine, Edwards, James O., Fullarton, John R., Sonderegger, Yum Lina Yip, Ghatnekar, Ola, Ghosh, Subrata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406809/ https://www.ncbi.nlm.nih.gov/pubmed/32879597 http://dx.doi.org/10.20524/aog.2020.0521 |
Ejemplares similares
-
Efficacy of oral prolonged‐release mesalazine in moderately active ulcerative colitis
por: Paridaens, Kristine, et al.
Publicado: (2023) -
Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease
por: Sood, Ajit, et al.
Publicado: (2020) -
5-Aminosalicylates to maintain remission in Crohn’s disease: Interpreting conflicting systematic review evidence
por: Gordon, Morris
Publicado: (2017) -
How Clinical Practice Research Datalink data are used to support pharmacovigilance
por: Ghosh, Rebecca E., et al.
Publicado: (2019) -
Presentation of SLE in UK primary care using the Clinical Practice Research Datalink
por: Nightingale, Alison L, et al.
Publicado: (2017)